Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?

Lancet Oncol. 2023 Feb;24(2):e65. doi: 10.1016/S1470-2045(22)00743-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chemoradiotherapy
  • Cisplatin / therapeutic use
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal*
  • Seminoma* / drug therapy
  • Seminoma* / pathology
  • Testicular Neoplasms* / drug therapy
  • Testicular Neoplasms* / radiotherapy

Substances

  • Cisplatin